REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activityJennifer S. Carew, Steffan T. Nawrocki, Claudia M. Espitia et al.|Cancer Letters|2025Cited by 8
Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced NephrotoxicityTrace M. Jones, Steffan T. Nawrocki, Jennifer S. Carew et al.|Cancer Research Communications|2023Cited by 7
Supplementary Table TS2 from Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced NephrotoxicityTrace M. Jones, Steffan T. Nawrocki, Claudia M. Espitia et al.|Unknown|2023Cited by 0
Supplementary Table TS1 from Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced NephrotoxicityTrace M. Jones, Steffan T. Nawrocki, Claudia M. Espitia et al.|Unknown|2023Cited by 0
Supplementary Figure S3 from Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced NephrotoxicityTrace M. Jones, Steffan T. Nawrocki, Benjamin R. Lee et al.|Unknown|2023Cited by 0